A Study of BBI608 and BBI503 Administered in Combination to Adult Patients With Advanced Solid Tumors
Clinical trial NCT02432326 · COMPLETED
Trial details
- NCT number
- NCT02432326
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2019-12-01
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.